Price T Rowe Associates Inc Immunome Inc. Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Immunome Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 2,245,673 shares of IMNM stock, worth $33.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,245,673
Previous 1,051,222
113.63%
Holding current value
$33.6 Million
Previous $11.2 Million
392.71%
% of portfolio
0.01%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding IMNM
# of Institutions
106Shares Held
32.1MCall Options Held
46.1KPut Options Held
32.5K-
Redmile Group, LLC San Francisco, CA4.89MShares$73 Million4.76% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$58 Million2.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.02MShares$30.2 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.64MShares$24.5 Million0.1% of portfolio
-
Janus Henderson Group PLC London, X01.54MShares$23 Million0.02% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $181M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...